Publications by authors named "Charles Bark"

Claim this Profile
P
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.
Ekaterina V Kurbatova, Kelly E Dooley, Wendy Carr, Jason E Stout, Eric L Nuermberger, Charles Bark

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Tuberculosis.
Grace Muzanyi, Charles M Bark

Med Clin North Am· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capturing Recent Infection by Tuberculin Skin Test vs. Interferon-Gamma Release Assay.
Jesús Gutierrez, Mary Nsereko, LaShaunda L Malone, Harriet Mayanja-Kizza, Hussein Kisingo, Charles M Bark

Trop Med Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More Tailored Approaches to Tuberculosis Treatment and Prevention.
Charles M Bark, W Henry Boom, Jennifer J Furin

Annu Rev Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.
Khalid M Dousa, Sebastian G Kurz, Charles M Bark, Robert A Bonomo, Jennifer J Furin

Infect Dis Clin North Am· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TB, or not TB, the Choice Is Ours.
Cyndee Miranda, Charles M Bark

Clin Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.
Catherine M Stein, Sarah Zalwango, LaShaunda L Malone, Bonnie Thiel, Ezekiel Mupere, Charles M Bark

Am J Epidemiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection.
Charles M Bark, Ameur M Manceur, LaShaunda L Malone, Mary Nsereko, Brenda Okware

EBioMedicine· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Resistant Tuberculosis: Challenges and Progress.
Sebastian G Kurz, Jennifer J Furin, Charles M Bark

Infect Dis Clin North Am· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnoses.
Sam Ogwang, Paul Mubiri, Charles M Bark, Moses L Joloba, W Henry Boom

Diagn Microbiol Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxis.
Sam Ogwang, Caryn E Good, Brenda Okware, Mary Nsereko, Michael R Jacobs, Charles M Bark

Antimicrob Agents Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in EBA in the first two days of standard anti-tuberculosis treatment in different geographic regions.
Charles M Bark, Phineas Gitta, John L Johnson

Int J Tuberc Lung Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapy.
Charles M Bark, Bonnie A Thiel, John L Johnson

J Clin Microbiol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer.
Charles M Bark, Rana S Traboulsi, Kord Honda, Autumn M Starnes, Michael R Jacobs

J Clin Microbiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV and the Kidney.
Leslie A Bruggeman, Charles Bark, Robert C Kalayjian

Curr Infect Dis Rep· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis